A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in loss or corruption of data.
Conclusion & alert: CVE-2018-10595 is rated Low Risk (36.8/100): CVSS Medium severity, with low exploitation likelihood (EPSS 0.41%). Mandatory action: Monitor for updates and reassess as exploit intelligence or EPSS changes.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2026-06-15 | 0.22% | 0.41% | +0.19% |
| 2 | 2025-03-30 | 0.51% | 0.22% | -0.29% |
| 3 | 2025-03-29 | — | 0.51% | — |
Full EPSS history (8 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 6.3 | 3.0 | MEDIUM |
|
0.4 | 5.9 | [email protected] |
| 4.9 | 2.0 | MEDIUM |
|
4.4 | 6.4 | [email protected] |
| URL | Tags |
|---|---|
| https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01 | Third Party Advisory US Government Resource |
| https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqula | Vendor Advisory |